(Q35084569)

6 August 2017

1 reference

title

The whys and hows of hematopoietic progenitor and stem cell mobilization (English)

1 reference

6 August 2017

Kessinger A

1

1 reference

6 August 2017

Sharp JG

series ordinal

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

Bone Marrow Transplantation

6 August 2017

1 reference

6 August 2017

31

1 reference

6 August 2017

5

1 reference

6 August 2017

319-329

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703837

6 August 2017

0 references

cites work

Hemopoietic Stem Cells in Human Peripheral Blood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Protection of lethally irradiated guinea pigs with fresh and frozen homologous peripheral blood leukocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Restoration of hematopoiesis in dogs by infusion of cryopreserved autologous peripheral white cells following busulfan-cyclophosphamide treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Transfusion of Circulating Stem Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Cure of aplastic anaemia in paroxysmal nocturnal haemoglobinuria by marrow transfusion from identical twin: Failure of peripheral-leucocyte transfusion to correct marrow aplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

High levels of circulating haemopoietic stem cells in very early remission from acute non-lymphoblastic leukaemia and their collection and cryopreservation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Autologous peripheral blood progenitor-cell transplantation versus autologous bone marrow transplantation for adults and children with non-leukaemic malignant disease. A randomised economic study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Stem cell mobilisation in lymphoproliferative diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Factors that influence collection and engraftment of autologous peripheral-blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of different doses of rhG-CSF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Peripheral blood stem cell mobilization with cyclophosphamide in combination with G-CSF, GM-CSF, or sequential GM-CSF/G-CSF in non-Hodgkin's lymphoma patients: a randomized prospective study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Erythropoietin addition to granulocyte colony-stimulating factor abrogates life-threatening neutropenia and increases peripheral-blood progenitor-cell mobilization after epirubicin, paclitaxel, and cisplatin combination chemotherapy: results of a ra

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Mobilization of peripheral blood progenitor cells in patients with breast cancer: a prospective randomized trial comparing rhG-CSF with the combination of rhG-CSF plus rhEpo after VIP-E chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Peripheral blood progenitor cell collection after epirubicin, paclitaxel, and cisplatin combination chemotherapy using EPO-based cytokine regimens: a randomized comparison of G-CSF and sequential GM-/G-CSF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Single vs twice daily G-CSF dose for peripheral blood stem cells harvest in normal donors and children with non-malignant diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Innovations in allogeneic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Management strategies for the hard-to-mobilize patient

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Effects of interleukin-6 on mobilization of primitive haemopoietic cells into the circulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Back-up bone marrow is frequently ineffective in patients with poor peripheral-blood stem-cell mobilization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 x 10(6) CD34+ cells/kg be considered the minimum threshold?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Blood stem cell transplantation: factors influencing cellular immunological reconstitution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Influence of CD34+ marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling tr

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Allogeneic transplantation of CD34(+) selected cells from peripheral blood from human leukocyte antigen-identical siblings: detrimental effect of a high number of donor CD34(+) cells?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Use of granulocyte colony-stimulating factor (G-CSF) for mobilizing peripheral blood stem cells: risk of mobilizing clonal myeloma cells in patients with bone marrow infiltration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Differential mobilization of CD34+ cells and lymphoma cells in non-Hodgkin's lymphoma patients mobilized with different growth factors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Characterization and outcome of "hard to mobilize"' lymphoma patients undergoing autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Multiple myeloma: the number of reinfused plasma cells does not influence outcome of patients treated with intensified chemotherapy and PBPC support

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Occult tumor contamination of hematopoietic stem-cell products does not affect clinical outcome of autologous transplantation in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Remobilization of patients who fail to achieve minimal progenitor thresholds at the first attempt is clinically worthwhile

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Progenitor cell yields are frequently poor in patients with histologically indolent lymphomas especially when mobilized within 6 months of previous chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

The CD3- 16+ 56+ NK cell count independently predicts autologous blood stem cell mobilization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Timing of platelet recovery is associated with adequacy of leukapheresis product yield after cyclophosphamide and G-CSF in patients with lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Effect of prior therapy and bone marrow metastases on progenitor cell content of blood stem cell harvests in breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

The use of mobilized peripheral blood stem cells from normal donors for allografting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Not all healthy donors mobilize hematopoietic progenitor cells sufficiently after G-CSF administration to allow for subsequent CD34 purification of the leukapheresis product

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Circulating factors may be responsible for murine strain-specific responses to mobilizing cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Concurrent partial body radiation prevents cytokine mobilization of blood progenitor cells: an effect mediated by a circulating factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Expression of adhesion molecules on CD34(+) cells in peripheral blood of non-hodgkin's lymphoma patients mobilized with different growth factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

High steady-state plasma levels of flt3-ligand in the peripheral blood is a good predictor for poor mobilization of CD34+ PBSC in patients undergoing high-dose chemotherapy and stem cell rescue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Increased serum flt3-ligand in healthy donors undergoing granulocyte colony-stimulating factor-induced peripheral stem cell mobilization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+ cells and/or CFU-GM with chemotherapy and G-CSF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Second attempts at mobilization of peripheral blood stem cells in patients with initial low CD34+ cell yields.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Simultaneous administration of G-CSF and GM-CSF for re-mobilization in patients with inadequate initial progenitor cell collections for autologous transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Successful autologous bone marrow rescue in patients who failed peripheral blood stem cell mobilization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Large-volume leukapheresis for collection of mononuclear cells for hematopoietic rescue in Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Progenitor cell yield in sequential blood stem cell mobilization in the same patients: insights into chemotherapy dose escalation and combination of haemopoietic growth factor and chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Re-mobilization of peripheral blood progenitor cells within a short time interval fails to achieve effective progenitor cell yields

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Peripheral blood stem cell apheresis in normal donors: feasibility and yield of second collections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Repeated peripheral stem cell mobilization in healthy donors: time-dependent changes in mobilization efficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703837

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703837

1 reference

Dimensions Publication ID

6 August 2017

0 references

1 reference